Shabnam Shalapour,Xue-Jia Lin,Ingmar N. Bastian,John Brain,Alastair D. Burt,Alexander A. Aksenov,Alison F. Vrbanac,Weihua Li,Andres Perkins,Takaji Matsutani,Zhenyu Zhong,Debanjan Dhar,Jose A. Navas-Molina,Jun Xu,Rohit Loomba,Michael Downes,Ruth T. Yu,Ronald M. Evans,Pieter C. Dorrestein,Rob Knight,Christopher Benner,Quentin M. Anstee,Michael Karin

Abstract:In this Article, the sentence: “After 7 months of HFD, MUP-uPA mice developed HCC15, which contained numerous (usually 50–100 per tumour) non-recurrent coding mutations in pathways that are mutated in human HCC (Fig. 2d and Extended Data Fig. 6a).”, should have read: “After 7 months of HFD, MUP-uPA mice developed HCC15, which contained numerous (usually 50–100 per tumour) non-recurrent mutations in pathways that are mutated in human HCC (Fig. 2d and Extended Data Fig. 6a).”. This has been corrected online. In Extended Data Fig. 6a and b, which show the number of point mutations identified per sample and the mutational signatures, all sequence variants (including non-coding mutations) are shown. Fig. 2d also presents all variants compared to human mutations. In the Supplementary Information to this Amendment, we now provide the comparisons of all variants and coding variants to human mutations.

Author Correction: Anti-tumour Immunity Controlled Through Mrna M 6 A Methylation and YTHDF1 in Dendritic Cells

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Corrigendum: RNA m6A methylation regulates the ultraviolet-induced DNA damage response.

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Author Correction: Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

Correction: Corrigendum: RNA m 6 A methylation regulates the ultraviolet-induced DNA damage response

Correction: Corrigendum: The transcriptional coactivator TAZ regulates reciprocal differentiation of T H 17 cells and T reg cells

Correction to: M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway

Publisher Correction: N6-Methyladenosine Methyltransferase ZCCHC4 Mediates Ribosomal RNA Methylation

Author Correction to “Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy” [acta Pharm Sin B 12 (2022) 4224–4234]

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Corrigendum: Antigen Presentation Machinery Signature-Derived CALR Mediates Migration, Polarization of Macrophages in Glioma and Predicts Immunotherapy Response

Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Corrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers

Erratum: Author Correction to "Tumor-Microenvironment Activated Duplex Genome-Editing Nanoprodrug for Sensitized Near-Infrared Titania Phototherapy" [acta Pharm Sin B (2022) 4224-4234].

Corrigendum: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening

Author Correction: A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis

Author Correction: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity